Speaker profile

Petrina Kamya

Global Head of AI Platforms, VP
Insilico Medicine

Dr. Petrina Kamya is a computational chemist specializing in computer-aided molecular design with a career spanning academic research and industry leadership roles. She earned her Ph.D. in theoretical chemistry from Concordia University, where she researched RNA structure interactions and small molecule design. Transitioning to industry, Dr. Kamya joined Chemical Computing Group (CCG) in Montreal where she played a pivotal role in sales and business development, focusing on molecular modeling software tailored for pharmaceutical and biotech companies and academic institutions. At Certara, she consulted for pharmaceutical companies, offering strategic insights on market access and drug commercialization.

At Insilico Medicine, she oversees the corporate strategy for the AI-driven platforms and services. Her expertise bridges computational chemistry and AI, driving innovation in molecular discovery.

Agenda sessions

Day 1 | September 30, 2025
15:32 (CEST)
Using Generative AI-Designed Small Molecule Inhibitors to Revolutionize IPF Treatment
Go to session
16:20 (CEST)
Panel Discussion and Q&A
Go to session